Zampilimab

佐比利单抗

Report date: 2026/04/09 20:00:21

Base Information

Drug NameZampilimab
Drug Alias NameUCB-7858CHF10067
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionProtein-glutamine gamma-glutamyltransferase inhibitors
TargetsProtein-glutamine gamma-glutamyltransferase
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineUnited KingdomMacedonia, The Former Yugoslav Republic of
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUcb Sa
China Registration ClassN/A

Develop Information

Active CompaniesUcb Biopharma SrlChiesi Farmaceutici SPA
Inactive CompaniesUcb Biopharma Sprl
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A